IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,173,275 | -87.6% | 30,562 | -94.3% | 0.00% | -98.3% |
| Q4 2022 | $9,475,660 | +913.4% | 533,840 | +218.6% | 0.17% | +861.1% |
| Q3 2022 | $935,000 | +232.7% | 167,570 | +408.5% | 0.02% | +100.0% |
| Q4 2021 | $281,000 | +103.6% | 32,956 | +108.1% | 0.01% | +125.0% |
| Q3 2021 | $138,000 | -62.8% | 15,835 | -54.9% | 0.00% | -69.2% |
| Q2 2021 | $371,000 | -42.0% | 35,145 | -11.9% | 0.01% | -64.9% |
| Q1 2021 | $640,000 | – | 39,886 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |